Executive Board
The Executive Board has been established to assist the Chief Executive in leading The Institute of Cancer Research to achieve its strategic aims and objectives within the approved strategies and budgets and is responsible for formulating strategies, plans and budgets for approval by the Board of Trustees.
Professor Kristian Helin
Chief Executive and President
Professor Kevin Harrington
Head of Division – Radiotherapy and Imaging
Professor Clare Isacke
Dean of Academic and Research Affairs
Paul Norris
Chief Financial Officer
Jonathan Monk
Chief Information Officer
Professor Jonathon Pines
Head of Division – Cell and Molecular Biology
Dr Barbara Pittam
Chief Research and Academic Officer
Dr Olivia Rossanese
Head of Division – Cancer Therapeutics
Dr Kary Kelly
Chief Development and Communications Officer
Latest ICR News
UK scientists create most detailed map yet of mutations that drive cancer
Scientists have created the most comprehensive map to date of the genetic mutations that fuel cancer – opening the door to extending precision treatments to thousands more patients and offering clues as to why bowel cancer rates are rising in younger people.
Why is animal research still necessary to defeat cancer?
In this feature, cancer scientists and animal research experts across The Institute of Cancer Research, London, discuss why breakthroughs gained by studying whole-body systems in animals are essential in understanding how cancer develops and behaves within a whole organism, and how to treat it effectively.
ICR scientists support promising new immunotherapy trial for advanced ovarian cancer
Scientists at The Institute of Cancer Research, London, are supporting an international clinical trial of a promising new immunotherapy treatment for advanced ovarian cancer.
New study reveals key enzyme as hidden driver of cancer stress responses
An important study has uncovered an unexpected molecular player that helps make cancer cells stress-resilient, thereby promoting the survival, growth and progression of cancer.